Cleary Gottlieb represented Burning Rock Biotech Limited (Burning Rock) in its direct listing on the London Stock Exchange (LSE).
On November 1, 2022, Burning Rock’s American depositary shares (ADSs) were admitted to the standard listing segment of the Official List of the FCA and to trading on the Main Market of the LSE by way of a direct listing.
Burning Rock’s listed ADSs will continue to be listed and traded on the Nasdaq Global Market, with those ADSs being fully fungible with the ADSs listed on the LSE.
Burning Rock is a company focused on the application of next-generation sequencing technology in the field of precision oncology.